Chief Executive Officer, Rinri Therapeutics
Simon is CEO of Rinri Therapeutics, responsible for the strategic direction and operation of the company. He has been involved since its inception and works closely with Marcelo Rivolta, Rinri’s founder.
Simon has deep knowledge and in-depth experience of the biotech sector and a strong understanding of the advanced therapeutics landscape, having spent most of his career within the blue-chip companies in the biotechnology and pharmaceutical industries. He joined Rinri from IP Group, a specialist venture capital firm, where he worked to identify transformative investment opportunities into exciting technology start-ups. This gave him broad exposure to the life sciences market across AI-diagnostics, medical devices, osteogenesis, synthetic biology, and antivirals.
Simon was attracted to the role at Rinri by the impressive pre-clinical data, showing a dramatic restoration of hearing in ontological disease models, and demonstrating the enormous potential for Rinri’s technology to make a real-world impact on patients and healthcare systems.
Simon holds a BSc. (Hons.) from Leeds University and a Ph.D. in Molecular Biology and Biochemistry from the University of York.